Nifenazone

DB13407

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 308.341
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1386 Data
Amlodipine Nifenazone may decrease the antihypertensive activities of Amlodipine.
Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Nifenazone.
Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Nifenazone.
Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Nifenazone.
Isoetharine The risk or severity of hypertension can be increased when Isoetharine is combined with Nifenazone.
Ziprasidone The risk or severity of hypertension can be increased when Ziprasidone is combined with Nifenazone.
Methysergide The risk or severity of hypertension can be increased when Methysergide is combined with Nifenazone.
Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Nifenazone.
Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Nifenazone.
Dihydroergotamine The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Nifenazone.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Nifenazone.
Norepinephrine The risk or severity of hypertension can be increased when Norepinephrine is combined with Nifenazone.
Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Nifenazone.
Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Nifenazone.
Phenylpropanolamine The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Nifenazone.
Promazine The risk or severity of hypertension can be increased when Promazine is combined with Nifenazone.
Droperidol The risk or severity of hypertension can be increased when Droperidol is combined with Nifenazone.
Doxapram The risk or severity of hypertension can be increased when Doxapram is combined with Nifenazone.
Atropine The risk or severity of hypertension can be increased when Atropine is combined with Nifenazone.
Lisuride The risk or severity of hypertension can be increased when Lisuride is combined with Nifenazone.
Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Nifenazone.
Metaraminol The risk or severity of hypertension can be increased when Metaraminol is combined with Nifenazone.
Furazolidone The risk or severity of hypertension can be increased when Furazolidone is combined with Nifenazone.
Epinephrine The risk or severity of hypertension can be increased when Epinephrine is combined with Nifenazone.
Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Nifenazone.
Ergotamine The risk or severity of hypertension can be increased when Ergotamine is combined with Nifenazone.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Nifenazone.
Sufentanil The risk or severity of hypertension can be increased when Sufentanil is combined with Nifenazone.
Methoxamine The risk or severity of hypertension can be increased when Methoxamine is combined with Nifenazone.
Risperidone The risk or severity of hypertension can be increased when Risperidone is combined with Nifenazone.
Tranylcypromine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Nifenazone.
Isoflurane The risk or severity of hypertension can be increased when Isoflurane is combined with Nifenazone.
Propiomazine The risk or severity of hypertension can be increased when Propiomazine is combined with Nifenazone.
Alfentanil The risk or severity of hypertension can be increased when Alfentanil is combined with Nifenazone.
Minaprine The risk or severity of hypertension can be increased when Minaprine is combined with Nifenazone.
Orciprenaline The risk or severity of hypertension can be increased when Orciprenaline is combined with Nifenazone.
Propofol The risk or severity of hypertension can be increased when Propofol is combined with Nifenazone.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Nifenazone.
Trifluoperazine The risk or severity of hypertension can be increased when Trifluoperazine is combined with Nifenazone.
Pseudoephedrine The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Nifenazone.
Benzphetamine The risk or severity of hypertension can be increased when Benzphetamine is combined with Nifenazone.
Ritodrine The risk or severity of hypertension can be increased when Ritodrine is combined with Nifenazone.
Flupentixol The risk or severity of hypertension can be increased when Flupentixol is combined with Nifenazone.
Remifentanil The risk or severity of hypertension can be increased when Remifentanil is combined with Nifenazone.
Bitolterol The risk or severity of hypertension can be increased when Bitolterol is combined with Nifenazone.
Oxymetazoline The risk or severity of hypertension can be increased when Oxymetazoline is combined with Nifenazone.
Diethylpropion The risk or severity of hypertension can be increased when Diethylpropion is combined with Nifenazone.
Salmeterol The risk or severity of hypertension can be increased when Salmeterol is combined with Nifenazone.
Naratriptan The risk or severity of hypertension can be increased when Naratriptan is combined with Nifenazone.
Formoterol The risk or severity of hypertension can be increased when Formoterol is combined with Nifenazone.
Frovatriptan The risk or severity of hypertension can be increased when Frovatriptan is combined with Nifenazone.
Methoxyflurane The risk or severity of hypertension can be increased when Methoxyflurane is combined with Nifenazone.
Selegiline The risk or severity of hypertension can be increased when Selegiline is combined with Nifenazone.
Ergoloid mesylate The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Nifenazone.
Isoprenaline The risk or severity of hypertension can be increased when Isoprenaline is combined with Nifenazone.
Arbutamine The risk or severity of hypertension can be increased when Arbutamine is combined with Nifenazone.
Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Nifenazone.
Halothane The risk or severity of hypertension can be increased when Halothane is combined with Nifenazone.
Moclobemide The risk or severity of hypertension can be increased when Moclobemide is combined with Nifenazone.
Pergolide The risk or severity of hypertension can be increased when Pergolide is combined with Nifenazone.
Desflurane The risk or severity of hypertension can be increased when Desflurane is combined with Nifenazone.
Bromocriptine The risk or severity of hypertension can be increased when Bromocriptine is combined with Nifenazone.
Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Nifenazone.
Aripiprazole The risk or severity of hypertension can be increased when Aripiprazole is combined with Nifenazone.
Isocarboxazid The risk or severity of hypertension can be increased when Isocarboxazid is combined with Nifenazone.
Ergometrine The risk or severity of hypertension can be increased when Ergometrine is combined with Nifenazone.
Lisdexamfetamine The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Nifenazone.
Fenoterol The risk or severity of hypertension can be increased when Fenoterol is combined with Nifenazone.
Pirbuterol The risk or severity of hypertension can be increased when Pirbuterol is combined with Nifenazone.
Ephedra sinica root The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Nifenazone.
Ephedrine The risk or severity of hypertension can be increased when Ephedrine is combined with Nifenazone.
Mephentermine The risk or severity of hypertension can be increased when Mephentermine is combined with Nifenazone.
Procaterol The risk or severity of hypertension can be increased when Procaterol is combined with Nifenazone.
Yohimbine The risk or severity of hypertension can be increased when Yohimbine is combined with Nifenazone.
Methotrimeprazine The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Nifenazone.
Clenbuterol The risk or severity of hypertension can be increased when Clenbuterol is combined with Nifenazone.
Bambuterol The risk or severity of hypertension can be increased when Bambuterol is combined with Nifenazone.
MMDA The risk or severity of hypertension can be increased when MMDA is combined with Nifenazone.
Midomafetamine The risk or severity of hypertension can be increased when Midomafetamine is combined with Nifenazone.
2,5-Dimethoxy-4-ethylamphetamine The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Nifenazone.
4-Methoxyamphetamine The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Nifenazone.
4-Bromo-2,5-dimethoxyamphetamine The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Nifenazone.
Tenamfetamine The risk or severity of hypertension can be increased when Tenamfetamine is combined with Nifenazone.
Chlorphentermine The risk or severity of hypertension can be increased when Chlorphentermine is combined with Nifenazone.
Dextroamphetamine The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Nifenazone.
Phendimetrazine The risk or severity of hypertension can be increased when Phendimetrazine is combined with Nifenazone.
Solifenacin The risk or severity of hypertension can be increased when Solifenacin is combined with Nifenazone.
Periciazine The risk or severity of hypertension can be increased when Periciazine is combined with Nifenazone.
Acepromazine The risk or severity of hypertension can be increased when Acepromazine is combined with Nifenazone.
Thioproperazine The risk or severity of hypertension can be increased when Thioproperazine is combined with Nifenazone.
Zuclopenthixol The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Nifenazone.
Epicaptopril The risk or severity of hypertension can be increased when Epicaptopril is combined with Nifenazone.
Clorgiline The risk or severity of hypertension can be increased when Clorgiline is combined with Nifenazone.
1-benzylimidazole The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Nifenazone.
Iproniazid The risk or severity of hypertension can be increased when Iproniazid is combined with Nifenazone.
Nialamide The risk or severity of hypertension can be increased when Nialamide is combined with Nifenazone.
Lysergic acid diethylamide The risk or severity of hypertension can be increased when Lysergic acid diethylamide is combined with Nifenazone.
Dronedarone The risk or severity of hypertension can be increased when Dronedarone is combined with Nifenazone.
Flibanserin The risk or severity of hypertension can be increased when Flibanserin is combined with Nifenazone.
Iloperidone The risk or severity of hypertension can be increased when Iloperidone is combined with Nifenazone.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul